[go: up one dir, main page]

MX9806064A - Composicion de enzimas para disociacion de tejidos. - Google Patents

Composicion de enzimas para disociacion de tejidos.

Info

Publication number
MX9806064A
MX9806064A MX9806064A MX9806064A MX9806064A MX 9806064 A MX9806064 A MX 9806064A MX 9806064 A MX9806064 A MX 9806064A MX 9806064 A MX9806064 A MX 9806064A MX 9806064 A MX9806064 A MX 9806064A
Authority
MX
Mexico
Prior art keywords
enzyme composition
collagenase
tissue dissociation
tissue
activity
Prior art date
Application number
MX9806064A
Other languages
English (en)
Inventor
Francis E Dwulet
Marilyn E Smith
Original Assignee
Boehringer Mannheim Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim Corp filed Critical Boehringer Mannheim Corp
Publication of MX9806064A publication Critical patent/MX9806064A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/067—Hepatocytes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/069—Vascular Endothelial cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2509/00—Methods for the dissociation of cells, e.g. specific use of enzymes

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Vascular Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

Se describe una composicion de enzimas y su uso para aislar células o agrupaciones celulares de tejido. La composicion incluye dos enzimas de colagenasa y una endoproteasa. La relacion de la actividad de caseína FITC total de la composicion de enzimas a las unidades Wunsch de actividad de las masas de colagenasa I y colagenasa II es de aproximadamente 85:1 hasta aproximadamente 3,900:1.
MX9806064A 1996-12-06 1998-07-28 Composicion de enzimas para disociacion de tejidos. MX9806064A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/760,893 US5830741A (en) 1996-12-06 1996-12-06 Composition for tissue dissociation containing collagenase I and II from clostridium histolyticum and a neutral protease

Publications (1)

Publication Number Publication Date
MX9806064A true MX9806064A (es) 1998-11-30

Family

ID=25060487

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9806064A MX9806064A (es) 1996-12-06 1998-07-28 Composicion de enzimas para disociacion de tejidos.

Country Status (8)

Country Link
US (2) US5830741A (es)
EP (1) EP0907723B1 (es)
JP (1) JP3053875B2 (es)
CA (1) CA2241266C (es)
DE (1) DE69735308T2 (es)
ES (1) ES2259194T3 (es)
MX (1) MX9806064A (es)
WO (1) WO1998024889A1 (es)

Families Citing this family (73)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5830741A (en) * 1996-12-06 1998-11-03 Boehringer Mannheim Corporation Composition for tissue dissociation containing collagenase I and II from clostridium histolyticum and a neutral protease
US6251604B1 (en) 1999-08-13 2001-06-26 Genopsys, Inc. Random mutagenesis and amplification of nucleic acid
US6428785B1 (en) 1999-10-28 2002-08-06 Immunolytics Inc. Method and composition for treating prostate cancer
US7045349B2 (en) * 2001-01-23 2006-05-16 Benedict Daniel J Method of islet isolation using process control
FR2823217A1 (fr) * 2001-04-09 2002-10-11 Oreal Procede d'obtention d'une suspension de cellules individualisees issues d'un equivalent de peau humaine reconstruite et applications
AU2002309330A1 (en) * 2001-05-17 2002-11-25 Isotis N.V. Isolation method of mesenchymal cells
US20030054331A1 (en) * 2001-09-14 2003-03-20 Stemsource, Inc. Preservation of non embryonic cells from non hematopoietic tissues
US20050048036A1 (en) * 2001-12-07 2005-03-03 Hedrick Marc H. Methods of using regenerative cells in the treatment of inherited and acquired disorders of the bone, bone marrow, liver, and other tissues
US7514075B2 (en) * 2001-12-07 2009-04-07 Cytori Therapeutics, Inc. Systems and methods for separating and concentrating adipose derived stem cells from tissue
US8105580B2 (en) 2001-12-07 2012-01-31 Cytori Therapeutics, Inc. Methods of using adipose derived stem cells to promote wound healing
US7595043B2 (en) * 2001-12-07 2009-09-29 Cytori Therapeutics, Inc. Method for processing and using adipose-derived stem cells
US9597395B2 (en) 2001-12-07 2017-03-21 Cytori Therapeutics, Inc. Methods of using adipose tissue-derived cells in the treatment of cardiovascular conditions
US8404229B2 (en) * 2001-12-07 2013-03-26 Cytori Therapeutics, Inc. Methods of using adipose derived stem cells to treat acute tubular necrosis
US20050095228A1 (en) 2001-12-07 2005-05-05 Fraser John K. Methods of using regenerative cells in the treatment of peripheral vascular disease and related disorders
US20060204556A1 (en) * 2001-12-07 2006-09-14 Cytori Therapeutics, Inc. Cell-loaded prostheses for regenerative intraluminal applications
DK1921133T3 (en) 2001-12-07 2015-08-24 Cytori Therapeutics Inc System for processing lipoaspiratceller
US7771716B2 (en) * 2001-12-07 2010-08-10 Cytori Therapeutics, Inc. Methods of using regenerative cells in the treatment of musculoskeletal disorders
US7651684B2 (en) 2001-12-07 2010-01-26 Cytori Therapeutics, Inc. Methods of using adipose tissue-derived cells in augmenting autologous fat transfer
US7585670B2 (en) 2001-12-07 2009-09-08 Cytori Therapeutics, Inc. Automated methods for isolating and using clinically safe adipose derived regenerative cells
US20050008626A1 (en) * 2001-12-07 2005-01-13 Fraser John K. Methods of using adipose tissue-derived cells in the treatment of cardiovascular conditions
EP1467746A4 (en) * 2001-12-20 2006-10-04 Macropore Inc SYSTEMS AND METHODS FOR TREATING PATIENTS WITH COLLAGEN-RICH MATERIAL EXTRACTED FROM ADIPOSE TISSUES
US20030198631A1 (en) * 2002-04-18 2003-10-23 Healthpoint, Ltd. Thermolysin enzymatic wound debrider
CN1742093A (zh) * 2002-11-18 2006-03-01 新加坡科技研究局 细胞和/或核酸分子分离的方法和系统
KR20120038534A (ko) 2003-02-20 2012-04-23 사이토리 테라퓨틱스, 인크. 심혈관 증상의 치료에 지방조직-유래 세포를 사용하는 방법
DE10331171A1 (de) 2003-07-09 2005-01-27 Nordmark Arzneimittel Gmbh & Co. Kg Neutrale Protease (NP) und Produkt unter Verwendung von neutraler Protease für Gewebedissoziation sowie Verfahren zu dessen Herstellung
EP2338441B1 (en) 2003-12-11 2013-01-23 Isto Technologies Inc. Particulate cartilage system
US7273756B2 (en) * 2004-10-01 2007-09-25 Isto Technologies, Inc. Method for chondrocyte expansion with phenotype retention
US8017394B2 (en) * 2004-10-01 2011-09-13 Isto Technologies, Inc. Method for chondrocyte expansion with phenotype retention
US20080140451A1 (en) * 2005-01-10 2008-06-12 Cytori Therapeutics, Inc. Devices and Methods for Monitoring, Managing, and Servicing Medical Devices
US20070224184A1 (en) * 2006-02-22 2007-09-27 The Research Foundation Of The State University Of New York Method for treating cellulite
KR20090130158A (ko) 2005-01-21 2009-12-17 더 리서치 파운데이션 오브 스테이트 유니버시티 오브 뉴욕 유착 관절낭염을 치료하는 방법
US20070015278A1 (en) * 2005-04-13 2007-01-18 Yuling Li Methods of isolating differentiable cells from placental-associated tissue and uses thereof
AU2006282754A1 (en) 2005-08-26 2007-03-01 Zimmer, Inc. Implants and methods for repair, replacement and treatment of joint disease
FR2890976B1 (fr) * 2005-09-20 2007-12-14 Univ La Reunion Kit pour preparer une composition comprenant des cellules adipocytaires et procede d'obtention de ladite composition
US7811560B2 (en) * 2006-01-30 2010-10-12 Auxilium Us Holdings, Llc Compositions and methods for treating collagen-mediated diseases
CA2644115C (en) * 2006-03-07 2015-02-24 Humacyte Method for endothelial cell extraction from adipose tissues
WO2007139551A1 (en) * 2006-05-30 2007-12-06 Cytori Therapeutics, Inc. Systems and methods for manipulation of regenerative cells from adipose tissue
WO2008013863A2 (en) * 2006-07-26 2008-01-31 Cytori Therapeutics, Inc. Generation of adipose tissue and adipocytes
EP1894581A1 (en) * 2006-08-31 2008-03-05 CellCoTec B.V. Repair of cartilage tissue using a matrix gel containing chondrocytes
US8323642B2 (en) * 2006-12-13 2012-12-04 Depuy Mitek, Inc. Tissue fusion method using collagenase for repair of soft tissue
US8163549B2 (en) 2006-12-20 2012-04-24 Zimmer Orthobiologics, Inc. Method of obtaining viable small tissue particles and use for tissue repair
US7632340B2 (en) * 2007-03-07 2009-12-15 Hamilton Beach Brands, Inc. Air purifier for removing particles or contaminants from air
CA2684040C (en) 2007-04-12 2016-12-06 Isto Technologies, Inc. Method of forming an implant using a mold that mimics the shape of the tissue defect site and implant formed therefrom
US10071143B1 (en) 2007-05-03 2018-09-11 The Research Foundation For The State University Of New York Methods for non-surgical treatment of carpal tunnel syndrome
US20100159564A1 (en) * 2007-11-30 2010-06-24 Dwulet Francis E Protease resistant recombinant bacterial collagenases
TWI395593B (zh) 2008-03-06 2013-05-11 Halozyme Inc 可活化的基質降解酵素之活體內暫時性控制
WO2010021993A1 (en) 2008-08-19 2010-02-25 Cytori Therapeutics, Inc. Methods of using adipose tissue-derived cells in the treatment of the lymphatic system and malignant disease
WO2010102262A1 (en) * 2009-03-06 2010-09-10 Halozyme, Inc. Temperature sensitive mutants of matrix metalloprotease 1 und uses thereof
WO2010105820A1 (en) 2009-03-19 2010-09-23 Roche Diagnostics Gmbh Improved blends containing proteases
EP2424463B1 (en) 2009-05-01 2016-12-28 Bimini Technologies LLC Systems, methods and compositions for optimizing tissue and cell enriched grafts
ES2385239B1 (es) 2010-09-30 2013-06-19 Proteos Biotech S.L.U. Uso de colagenasa g recombinante, colagenasa h recombinante y pz-peptidasa recombinante para el tratamiento de enfermedades que cursan con alteraciones del colágeno.
KR101921353B1 (ko) * 2011-03-16 2018-11-23 도호쿠 다이가쿠 생체 조직 분석용 프로브 및 그 이용법
US10119131B2 (en) 2011-03-16 2018-11-06 Biospecifics Technologies Corp. Compositions and methods for producing clostridial collagenases
PT3584317T (pt) 2012-01-12 2022-01-26 Endo Global Ventures Enzima de clostridium histolyticum
BR102012013110A2 (pt) 2012-05-31 2014-05-27 Cristalia Prod Quimicos Farm Meio de cultura para bactérias do gênero clostridium livre de componentes de origem animal e processo para produção de sobrenadante contendo uma ou mais proteases com atividade colagenolítica e gelatinolítica
EP2870173B1 (en) * 2012-07-09 2018-10-17 Roche Diagniostics GmbH Recombinantly produced neutral protease originating from paenibacillus polymyxa
WO2014066622A2 (en) 2012-10-24 2014-05-01 The Research Foundation For The State University Of New York Use of collagenase to treat glaucoma
US20140178343A1 (en) 2012-12-21 2014-06-26 Jian Q. Yao Supports and methods for promoting integration of cartilage tissue explants
CN105008519A (zh) 2013-02-01 2015-10-28 国立大学法人东北大学 从生物组织分离细胞的方法
US9744138B2 (en) 2013-03-15 2017-08-29 Biospecifics Technologies Corp. Treatment method and product for uterine fibroids using purified collagenase
WO2015042182A1 (en) 2013-09-19 2015-03-26 Cytori Therapeutics, Inc. Methods of using adipose tissue-derived cells in the modulation of pain and/or fibrosis
CN103751102A (zh) 2014-01-15 2014-04-30 上海交通大学 一种胶原酶温敏水凝胶及其制备方法和应用
JPWO2017038473A1 (ja) * 2015-08-28 2018-06-14 天野エンザイム株式会社 エンドトキシン低減サーモリシン
EP3368668B1 (en) 2015-10-28 2023-11-29 Silicon Valley Scientific, Inc. Method and apparatus for encoding cellular spatial position information
DK3384287T3 (da) * 2015-12-01 2021-03-29 Medical Res Infrastructure & Health Services Fund Tel Aviv Medical Ct Forbedrede cytometriske analyser
ITUB20161010A1 (it) * 2016-02-24 2017-08-24 Abiel S R L Metodo di calibrazione di collagenasi
WO2018102471A1 (en) 2016-11-29 2018-06-07 S2 Genomics, Inc. Method and apparatus for processing tissue samples
PT3589204T (pt) 2017-03-01 2025-07-18 Endo Operations Ltd Aparelho e método de avaliação e tratamento da celulite
EP3601556A2 (en) 2017-03-28 2020-02-05 Endo Ventures Limited Improved method of producing collagenase
US12103004B2 (en) 2018-03-12 2024-10-01 Silicon Valley Scientific, Inc. Method and apparatus for processing tissue and other samples encoding cellular spatial position information
AU2019279085A1 (en) 2018-06-01 2021-01-07 S2 Genomics, Inc. Method and apparatus for processing tissue samples
WO2020174005A1 (en) 2019-02-28 2020-09-03 The Regenerative Group Ltd. Regenerative combination of plasma and adipose tissue
EP4045078A1 (en) 2019-10-15 2022-08-24 The Johns Hopkins University Treatment of uterine fibroids using purified collagenase

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3201325A (en) * 1963-02-15 1965-08-17 Miles Lab Process for the recovery of collagenase
US3821364A (en) * 1966-07-08 1974-06-28 Advance Biofactures Corp Process of producing collagenase
US3705083A (en) * 1966-07-08 1972-12-05 Agricultural Biolog Corp Process for producing collagenase
DE2801238C2 (de) * 1977-01-27 1986-06-05 (Zaidanhojin) Sagami Chemical Research Center, Tokio/Tokyo Verfahren zur Herstellung von Salzen aus L,L-Dipeptiden und Phenylalaninestern
JPS5565214A (en) * 1978-11-10 1980-05-16 Bridgestone Corp Preparation of flame-resistant polyisocyanurate foam
DE3271828D1 (en) * 1981-04-27 1986-07-31 Health Lab Service Board High pressure liquid affinity chromatography
EP0064378B1 (en) * 1981-04-27 1987-02-11 The Public Health Laboratory Service Board Affinity chromatography using metal ions
AU568626B2 (en) * 1983-01-05 1988-01-07 Institut Pasteur Preparation having a high collagenolytic activity and pharmaceutical compositions containing it
US4868121A (en) * 1985-02-07 1989-09-19 Mcdonnell Douglas Corporation Islet isolation process
US4873359A (en) * 1985-10-21 1989-10-10 W. R. Grace & Co. - Conn. Process for preparing as partyl-phenylalanine dipeptides
GB8604497D0 (en) * 1986-02-24 1986-04-03 Connaught Lab Separation of islets of langerhans
US5079160A (en) * 1987-06-08 1992-01-07 Lacy Paul E Method to isolate clusters of cell subtypes from organs
US5116615A (en) * 1989-01-27 1992-05-26 Immunolytics, Inc. Method for treating benign prostatic hypertrophy
US5120656A (en) * 1989-08-18 1992-06-09 Osteotech, Inc. Process for debriding bone
US4946792A (en) * 1989-08-18 1990-08-07 Osteotech, Inc. Process for debriding bone
US5177017A (en) * 1990-03-22 1993-01-05 Trigen, Inc. Molecular cloning of the genes responsible for collagenase production from Clostridium histolyticum
US5173295A (en) * 1990-10-05 1992-12-22 Advance Biofactures Of Curacao, N.V. Method of enhancing the regeneration of injured nerves and adhesive pharamaceutical formulation therefor
US5273904A (en) * 1992-03-18 1993-12-28 Cobe Laboratories, Inc. Apparatus for purifying islets of Langerhans
US5332503A (en) * 1993-04-16 1994-07-26 Baxter International Inc. Process for purifying collagenase
US5422261A (en) * 1993-04-16 1995-06-06 Baxter International Inc. Composition containing collagenase and chymopapain for hydrolyzing connective tissue to isolate cells
WO1996000283A1 (en) * 1994-06-24 1996-01-04 Boehringer Mannheim Corporation A purified mixture of collagenases and two other proteases obtained from clostridium histolyticum
WO1996028543A1 (de) * 1995-03-16 1996-09-19 Knoll Aktiengesellschaft Neue, definierte enzymmischungen zur zellgewinnung und für die wundbehandlung
US5830741A (en) * 1996-12-06 1998-11-03 Boehringer Mannheim Corporation Composition for tissue dissociation containing collagenase I and II from clostridium histolyticum and a neutral protease

Also Published As

Publication number Publication date
CA2241266A1 (en) 1998-06-11
DE69735308T2 (de) 2006-10-19
EP0907723A4 (en) 2003-02-05
ES2259194T3 (es) 2006-09-16
US5830741A (en) 1998-11-03
WO1998024889A1 (en) 1998-06-11
US5952215A (en) 1999-09-14
JPH11504225A (ja) 1999-04-20
EP0907723B1 (en) 2006-02-22
DE69735308D1 (de) 2006-04-27
EP0907723A1 (en) 1999-04-14
JP3053875B2 (ja) 2000-06-19
CA2241266C (en) 2001-11-27

Similar Documents

Publication Publication Date Title
MX9806064A (es) Composicion de enzimas para disociacion de tejidos.
WO1999011758A3 (en) Cultures of human cns neural stem cells
BG103977A (en) Low molecular rotamase enzymic activity inhibitors
CA2189646A1 (en) A Purified Mixture of Collagenases and Two Other Proteases Obtained from Clostridium Histolyticum
BR9405351A (pt) Ação combinada de endoglucanases e celobioidrolases
DE69535328D1 (de) In-vitro wachstum von langerhans'schen inseln und ihre verwendungen
ZA981936B (en) Novel benzimidazole inhibitors of fructose 1,6-bisphosphatase.
MX9604313A (es) Amilasa de bacillus alcalino.
CA2285430A1 (en) Calcium phosphate microcarriers and microspheres
AU563644B2 (en) Hydroxy substituted peptides
EP0832297A4 (en) METHOD AND COMPOSITIONS FOR IDENTIFYING BONE-FORMING SUBSTANCES
ES8801930A1 (es) Procedimiento para la preparacion de dipeptidos de n,n'-dialquilguanidino
DK0675951T3 (da) Enzym med endoglucanaseaktivitet
AU1617595A (en) Use of alkaline proteases in commercial laundry methods
ES2122145T3 (es) Fosfiniloximetil-cetonas peptidicas como inhibidores de la enzima convertida de la interleuquina-1 beta.
IL117479A0 (en) Enzymes obtained from clostridium histolyticum and their uses
AU687623B2 (en) Cell Adhesion peptides for use in modifying mutual adhesion among eukaryotic cells
AU4639297A (en) Enzyme having s-adenosyl-l-homocysteine hydrolase (ahcy) type activity
AU583499B2 (en) Amino thiol dipeptides
NO180643C (no) Alkalisk pullulanase Y med <alfa>-amylaseaktivitet og en biologisk renkultur av Bacillus sp. mikroorganisme som produserer denne
DE69428909D1 (de) Für die immun- und cns-therapie nutzbare, neuartige tripeptide
EP1772517A3 (en) DSP-3 dual specificity phosphatase
ES8609470A1 (es) Procedimiento para la inmovilizacion de celulas de bacillus subtilis
AU1402495A (en) Use of macrophage depleting agents for prolonging the survival of non-autologus hematopoietic cell transplants and animal model assay systems
AU5126596A (en) Use of gelatinase b and related enzymes to mobilize hematopo ietic stem cells for blood stem cell transplantation